Knowing that some cancer cells exhibit mutations in tyrosine kinase receptors, which lead to a constitutive receptor activation triggering the downstream pathways, it can be speculated that myoferlin depletion could impede cell proliferation in these cases. The gene discussed is MYOF; the disease is cancer.